Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1

Scritto il 15/03/2026
da Mohamed El-Tanani

No abstract

Discov Oncol. 2026 Mar 14. doi: 10.1007/s12672-026-04852-1. Online ahead of print.

NO ABSTRACT

PMID:41832248 | DOI:10.1007/s12672-026-04852-1